pifithrin has been researched along with Gait Disorders, Animal in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campana, AL | 1 |
| Rondi-Reig, L | 1 |
| Tobin, C | 1 |
| Lohof, AM | 1 |
| Picquet, F | 1 |
| Falempin, M | 1 |
| Weitzman, JB | 1 |
| Mariani, J | 1 |
1 other study available for pifithrin and Gait Disorders, Animal
| Article | Year |
|---|---|
p53 inactivation leads to impaired motor synchronization in mice.
Topics: Animals; Benzothiazoles; Cerebellum; Lameness, Animal; Male; Mice; Mice, Inbred C57BL; Mice, Knockou | 2003 |